| Literature DB >> 31489306 |
Matteo Donadon1,2, Nina Cortese3, Federica Marchesi2,4, Matteo Cimino1, Alberto Mantovani2,3,5, Guido Torzilli1,2.
Abstract
The burgeoning field of cancer immunology demands a change in the paradigm of cancer patient management. The understanding of the course of a given malignant disease should also include the host immune system as one of the key factors in determining the patient's prognosis. Surgical and medical oncologists need to understand the basic and advanced applications of immunotherapies, which are rapidly evolving, and are nowadays an integral part of the armamentarium for the treatment of cancer patients. In the present work, we review the current knowledge concerning the immune landscape of colorectal cancer (CRC) patients with liver metastases, as recently discovered.Entities:
Keywords: Host immune system; colorectal cancer (CRC); colorectal cancer liver metastases; colorectal liver metastases (CLM); immune response; immunotherapy
Year: 2019 PMID： 31489306 PMCID： PMC6700021 DOI： 10.21037/hbsn.2019.03.06
Source DB: PubMed Journal: Hepatobiliary Surg Nutr ISSN： 2304-3881 Impact factor: 7.293